|
Andreu JM, Roldán V, García-Navarro M, Ruipérez JA, Valdés M, Marín F. [Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence]. Arch Cardiol Mex. 2012 Jul-Sep;82(3):248-51. doi: 10.1016/j.acmx.2012.03.002. Epub 2012 Sep 14. Spanish. PubMed PMID: 23021363.
AÑO: 2012; IF: 4.78
|
23021363
|
Caballero L, Ruiz-Nodar JM, Marín F, Roldán V, Hurtado JA, Valencia J, Manzano-Fernandez S, Sogorb F, Valdes M, Lip GY. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting. Age Ageing. 2013 Jan;42(1):70-5. doi: 10.1093/ageing/afs121. PubMed PMID: 22983982.
AÑO: 2013; IF: 3.107
|
|
?xml version="1.0" encoding="utf-8"?> <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <pre> 1. Error occurred: cannot get document summary PMID: 22963074
AÑO: 2012
|
|
Roldán V, Marín F. Pro: "Antidote for new anticoagulants"--specific target of inhibition requires a specific target for neutralisation. Thromb Haemost. 2012 Oct;108(4):621-2. Epub 2012 Aug 23. Review. PubMed PMID: 22918294.
AÑO: 2012; IF: 6.094
|
|
Ruiz-Nodar JM, Marín F, Roldán V, Valencia J, Manzano-Fernández S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv. 2012 Aug 1;5(4):459-66. doi: 10.1161/CIRCINTERVENTIONS.112.968792. Epub 2012 Jul 10. PubMed PMID: 22787018.
AÑO: 2012; IF: 6.543
|